Hematology drugs
13 results
Accrufer (ferric maltol)
(Ferric Maltol)Shield TX (UK) Ltd
Usage: ACCRUFER is indicated for the treatment of iron deficiency in adults.
Actimmune (interferon gamma-1b)
(Interferon gamma-1b)Horizon Therapeutics USA, Inc.
Usage: ACTIMMUNE is indicated for reducing the frequency and severity of serious infections in patients with Chronic Granulomatous Disease (CGD) and for delaying disease progression in those with severe, malignant osteopetrosis (SMO).
Alprolix (coagulation factor ix (recombinant), fc fusion protein)
(Coagulation Factor IX (Recombinant), Fc Fusion Protein)Bioverativ Therapeutics Inc.
Usage: ALPROLIX is indicated for adults and children with hemophilia B for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce bleeding frequency. It is not intended for immune tolerance induction.
Altuviiio (antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl)
(Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl)Bioverativ Therapeutics Inc.
Usage: ALTUVIIIO is indicated for adults and children with hemophilia A to reduce bleeding episodes through routine prophylaxis, on-demand treatment, and perioperative management. It is not indicated for treating von Willebrand disease.
Benefix (coagulation factor ix (recombinant))
(coagulation factor ix (recombinant))Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
Usage: BeneFIX® is indicated for adults and children with hemophilia B for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce bleeding frequency. It is not intended for immune tolerance induction in hemophilia B patients.
Beqvez (fidanacogene elaparvovec-dzkt)
(fidanacogene elaparvovec-dzkt)Pfizer Laboratories Div Pfizer Inc
Usage: BEQVEZ is a gene therapy for adults with moderate to severe hemophilia B, indicated for those on factor IX prophylaxis, experiencing life-threatening hemorrhages or serious spontaneous bleeding, and without neutralizing antibodies to AAVRh74var capsid, based on FDA-approved diagnostics.
Cystadane (betaine)
(betaine)Rare Disease Therapeutics, Inc.
Usage: Cystadane® (betaine anhydrous) is indicated for treating homocystinuria to reduce elevated homocysteine levels. It is used for conditions including cystathionine beta-synthase deficiency, 5,10-methylenetetrahydrofolate reductase deficiency, and cobalamin cofactor metabolism defects.
Doptelet (avatrombopag maleate)
(avatrombopag maleate)AkaRx, Inc.
Usage: DOPTELET is indicated for treating thrombocytopenia in adult patients with chronic liver disease undergoing procedures and in those with chronic immune thrombocytopenia who have not responded adequately to prior treatments.
Eloctate (antihemophilic factor (recombinant), fc fusion protein)
(Antihemophilic Factor (Recombinant), Fc Fusion Protein)Bioverativ Therapeutics Inc.
Usage: ELOCTATE is indicated for adults and children with Hemophilia A for on-demand treatment of bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency. It is not intended for treating von Willebrand disease.
Hemangeol (propranolol hydrochloride)
(propranolol hydrochloride)Pierre Fabre Pharmaceuticals, Inc.
Usage: HEMANGEOL oral solution, containing propranolol hydrochloride, is indicated for the treatment of proliferating infantile hemangiomas that require systemic therapy.